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Description

Planning for resumption of patient care services during and following the impact of novel
coronavirus disease-2019 (COVID-19) while controlling costs are essential for pharmacy
services resiliency. Implementation of a pharmacy services reboot roadmap across a 179
hospital health-system is described. The roadmap encompassed eight key areas: pharmacy
leadership, staffing and scheduling, clinical pharmacy services, medication safety, medication supply, regulatory and compliance, team support opportunities, and financial stewardship. A supporting checklist and volume-based staffing plan are included as examples to
assist pharmacy leaders in planning optimal pharmacy services support as patient volumes
increase, particularly in the emergency department, surgical services and critical care areas.
Resiliency strategies are provided as tangible planning considerations to assess the current
status of, and prepare for, future operational and clinical pharmacy practice needs to support optimal patient care.
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Introduction

The first case of novel coronavirus disease 2019
(COVID-19) caused by severe acute respiratory coronavirus 2 (SARS-CoV-2) in the United
States (U.S.) was reported on January 22,
2020, with numerous patients requiring hospitalization in subsequent months.1 Nearly 94.5%
of the U.S. population was ordered to remain
at home as COVID-19 quickly spread.2 Hospitals
reported a significant decrease in the number
of patients admitted for treatment of nonCOVID-19 associated conditions such as heart
attacks, strokes, appendicitis and gallbladder
infections.3 Such a change in behavior suggests
people believe visiting a hospital may expose
them to COVID-19.3
The American College of Surgeons, the Centers
for Medicare and Medicaid Services and the
Centers for Disease Control and Prevention

were among the organizations that recommended hospitals to postpone or cancel elective surgeries for the purpose of conserving
or shifting health care resources to manage
the COVID-19 pandemic.4-6 The loss of revenue
generated by elective surgeries, in addition
the decrease in patients seeking treatment for
non-COVID-19 associated conditions, has had a
negative financial impact on many hospitals.3,7
When stay at home orders were lifted, health
systems and hospitals had to prepare to resume elective surgeries and other services that
were postponed during the pandemic.4,6,8
As providers and nurses prepare to resume
elective surgeries, procedures and routine
health care visits, clinical pharmacists continue
to optimize patient medication therapy, promote general health and perform vaccinations
to prevent disease. To best prepare pharmacy
services during and after the COVID-19 pan-
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demic, pharmacist leaders in our health system
created a reboot roadmap across 179 hospitals
encompassing 8 key areas: pharmacy leadership, staffing and scheduling, clinical pharmacy
services, medication safety, medication supply,
regulatory and compliance, team support and
financial stewardship. Having supporting toolkits, checklists and guidance for each of the key
areas enhances pharmacy department planning
for a diverse range of comprehensive patient
care services, including increased emergency
department and elective surgical services cases
that were anticipated during the reboot. Communicating the message clearly to local senior
leadership is intertwined throughout the roadmap to support financial stewardship efforts.
Various reboot strategies our health system is
using are discussed in terms of the 8 key areas
with successful implementation suggestions
for pharmacy leaders to consider when planning for resiliency.

Setting

Our health system is a leading provider of
health care in the United States with nearly
35 million patient encounters, 1.9 million hospital admissions and 9.2 million emergency
department visits annually. Our health system
consists of 179 acute care hospitals and nearly
2,000 sites of care including surgery centers,
freestanding emergency rooms, urgent care
centers and physician clinics in 21 states. Our
system employs approximately 5,500 pharmacists.
In a 2019 survey of hospitals in our health system, the majority of pharmacy departments
continue to schedule and allocate pharmacists
to meet the core clinical pharmacy program
elements. Of 133 respondent pharmacy service
department teams in these hospitals, 69%
reported the central pharmacy open 24/7 and
66% reported ≥ 51% of unit-based pharmacist
time dedicated to direct patient care activities
during first shift. While pharmacy hours of
operation differ depending on hospital characteristics and local community needs, the core
clinical pharmacy program elements are provided 24 hours/day, 7 days per week, utilizing
remote pharmacy teams. These core elements
include antimicrobial management, anticoagulation monitoring, basic nutrition support,
intravenous to oral conversion, pain manage-
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ment, medication safety, skill set and competency expectations, formulary management
and visibility and communication.

Pharmacy Leadership: Direct
Pharmacy Leaders in Guiding and
Supporting Reboot Plans

To assist pharmacy leadership with planning
ahead for potential changes and the resumption of certain patient care areas within the
hospital during and following the COVID-19
pandemic, a checklist of tasks with accompanying tools to support reboot plans was created.
(Table 1) Frequent pharmacy leader communications are recommended with hospital executives for reboot and financial resiliency discussions to assure alignment with hospital goals
and for pharmacy services visibility and support
during the reboot period.
Additionally, it is recommended that the director of pharmacy meet regularly with the pharmacy team during daily shift huddles and staff
meetings for the purpose of departmental
awareness and communication. Huddle talking
points include addressing the staffing plan to
position the team well; reminding the team of
the importance of visibility, especially during
interdisciplinary rounds; continuing to address
medication safety by reporting medication errors; and managing regulatory and compliance
changes, such as personal protective equipment (PPE) use and removal of temporary
pandemic user access to medications when no
longer required.

Staffing and Scheduling: Evaluate
Hospital Staffing Model and
Strategy
Incorporating staffing and scheduling plans
into the overarching business strategy is essential for pharmacy leaders during this reboot
phase. Leaders must understand, optimize and
protect pharmacy services staff to ensure that
the comprehensive patient care coverage is
provided for all patients served based on hospital-specific data during peak, moderate and
low volume cycles. As critical care units in some
areas of the U.S. continue to surge, pharmacist-to-patient ratios may require adjustment.9
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Table 1. Surgical/Procedural Acceleration Checklist
Complete

Task

Start Date

Completed
Date

ASSESS HOSPITAL INVENTORY
Assess current inventory of procedural medications (e.g., paralytics, sedation medications, antibiotics, reversal agents, blood
pressure medications, narcotics)
COMPLETE EXPIRATION CHECKING
Check anesthesia carts, operating room satellites, and procedural
areas for expired meds
REFILL PROCEDURAL AREAS TO MAXIMUM PAR LEVELS
Increase pars to standard and fill to maximum levels for automated dispensing cabinets (ADCs) and procedural areas where
medications were unloaded or pars decreased
CALCULATE NEEDED MEDICATIONS
Discuss with operating room staff and physicians/providers anticipated surgical cases by day of week, volume, and type
Calculate days’ supply available for procedural medications based
on historical usage and current medication supply
Determine number of medications needed from third party vendors used (e.g., cardioplegia, anesthesia syringes, narcotic drips)
and order with appropriate lead time
Order medications for upcoming cases (e.g., use ADC use report to
determine what is needed for future cases)
Review operating room schedule the day before surgeries to assess patient needs, staffing, and medication compounding
Address supply order backorders or substitutions
Order appropriate medications for pre-operative, post-anesthesia
care unit, procedural, and post-operative care areas
COMMUNICATE WITH ANESTHESIA
Communicate product shortages with the anesthesia team and
resolve medication supply concerns before the operating room go
live date
Discuss operating room scheduling with the anesthesia team to
align medication supply needs with daily replenishment times
ADDRESS ROUTINE PHARMACY STAFFING NEEDS FOR NORMAL HOURS
Review staffing needs and schedule staff at appropriate levels in
the pharmacy the day before go live and the day of go live
Review staffing needs and schedule staff at appropriate levels in
the pharmacy several days before go live to allow for compounding
of medications with appropriate beyond use dating
Review staffing with remote order verification one day before
go live and the day of go live (e.g., pre-operative/post-operative
orders, administration orders)
DETERMINE PHARMACY STAFFING NEEDS FOR EXTENDED HOURS
Review weekend staffing needs in the main pharmacy and pharmacy satellites
Plan ADC refills and compounding in those areas over extended
hours including weekends, if necessary
Assess remove order verification staffing needs for after hours and
weekends
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Table 1. Con’t
Complete

Task

Start Date

Completed
Date

ENSURE PHARMACIST EDUCATION AND TRAINING FOR UNITS COVERED
Provide education and training for pharmacists scheduled in units
(i.e., critical care and surgical units) they do not typically cover
Review surgical prophylaxis guidance with pharmacists scheduled
to cover surgical units
Provide a refresher for automated dispensing cabinets in anesthesia/operating room areas for pharmacists scheduled to cover surgical/operating room areas
ASSESS OPERATING ROOM SAFETY
Verify pharmacy prepares standardized solutions and medications
requiring compounding and dilution, particularly high-alert medications
Assure tallman lettering is in use
Validate all medications are clearly labeled
Pharmacy restocks and standardizes medication trays
Avoid purchasing look—alike products
Assure order sets are used
Perform bar code medication administration if available
Use smart pumps for medication infusions

Our roadmap also includes a staffing model
tool that calculates the number of staff needed
to provide care based on patient volume.
(Table 2) Remote order verification pharmacist
service needs are determined based on volume
and budgeted by hour. Technician staffing, particularly for compounding, as patient volumes
increase, is also a consideration (e.g., evaluate
batching needs with future operating room
schedules, beyond use dating of products and
PPE availability). A pharmacy services staffing assessment detects gaps in departmental
scheduling (i.e., shifts covered) and pharmacist-to-patient ratio allocation. This is particularly useful to determine the need to increase
staff for surgical services, emergency departments and critical care areas as volumes return
to baseline.

Clinical Pharmacy Services: Guide
Clinical Pharmacists to Optimally
Care for Patients and Preserve
Financial Resiliency

Many of our hospitals have unit-based clinical
pharmacists rounding with interdisciplinary
teams. As a result of COVID-19 patient surges
that continue, pharmacists who do not typically
328

cover critical care units may be scheduled to
provide care for the most critically ill patients.
Education and training must be provided to
ensure competence of rounding clinical pharmacists.9,10 A two-tiered approach has been
recommended, allowing more experienced
pharmacists to direct the less-experienced.9
Anticipating the need for education, a critical
care series primer and treatment guidelines are
available as resources to cross-covering pharmacists for critically ill patients. ASHP’s toolkit
for patient surge management may be helpful, especially in predicting certain medication
needs for the care of COVID-19 patients.11
To prepare for redeploying clinical pharmacists
back to the unit-based model, clinical pharmacy
managers are reviewing and sharing the importance of making clinical pharmacists available
and easily accessible to physicians, nurses and
leadership. Working with the interdisciplinary
team will allow pharmacists to provide patients
with the best possible care. Basic pharmacy
services guidance and expectation of care are
included for medication safety, antimicrobial
management program and pharmacy directed
services (e.g. anticoagulation monitoring, nutrition support, intravenous to oral conversion,
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Table 2. Pharmacy Services Volume-Based Staffing Considerations
Instructions:
For the patient care area with unit-based pharmacist coverage before COVID-19, please use the information below and in Table 3 to assess pharmacy services volume-based staffing considerations. An example
for the Critical Care patient care area is provided at the bottom of this table.
1. Name of Patient Care Area (Column 1): ___________
2. Pre-COVID-19 Baseline Patient Volume: ____number of patients
3. Unit-based pharmacist coverage before COVID-19: ____pharmacist FTE ____hours/day ____days of
week
4. Post-COVID-19 Patient Volume: _____total number of patients on patient care area, _____number of
patients on patient care area COVID-19+
5. Determine volume increase back to baseline before COVID-19 (Column 2): Post-COVID-19 patient
volume / Pre-Covid-19 baseline patient volume x 100%
6. Determine percent COVID-19+ patients for the patient care area, if applicable (Column 4): number of
patients on patient care area COVID-19+/total number of patients on patient care area x 100%
7. Using percent results in Columns 2 and 4, locate the closest match in Column 3 to determine percent
unit-based pharmacist hours to staff
8. Determine recommended pharmacist FTE for the patient care area: Percent Unit-Based Pharmacist
Hours to Staff result (Column 3) x pharmacist FTE before COVID-19
Note the staffing requirements will change based on number of patients, severity of illness, and preCOVID-19 staffing.
Column 1: Patient Care
Area
Surgical Services
(Medical/Surgical Units
Reopened)
Emergency
Department
Critical Care

Column 2: Volume Increase Back to Baseline
Before COVID-19

Column 3: Percent UnitBased Pharmacist Hours
to Staff*

Column 4: Percent
COVID-19+ Patients†

50%

Staff at 25-50%

-

75%

Staff at 50-75%

-

100%

Staff at 75-100%

-

50%

Staff at 25-50%

-

75%

Staff at 50-75%

-

100%

Staff at 75-100%

-

50%

Staff at 25-50%

0%

75%

Staff at 50-75%

25-50%

100%

Staff at 75-100%

50-75%

120%

Staff at 100-120%

75-100%

Example:
1. Name of Patient Care Area (Column 1): Critical Care
2. Pre-COVID-19 Baseline Patient Volume: 30 patients
3. Unit-based pharmacist coverage before COVID-19:
a. 1 pharmacist FTE 8 hours/day Mo-Fr days of week
4. Post-COVID-19 Patient Volume: 15 patients:
a. 11 non-COVID-19 patients, 4 patients COVID-19+
5. Volume increase back to baseline before COVID-19 (Column 2):
a. 15/30 x 100% = 50%
6. Determine percent COVID-19+ patients for the patient care area, if applicable (Column 4): 4/15 x 100%
= ~25%
7. Using percent results in Columns 2 (50%) and 4 (25%), locate the closest match in Column 3 to determine percent unit-based pharmacist hours: The closest match is Staff at 50-75%. Since the Percent
COVID-19+ Patients result (Column 4) is 25%, Staff at 50% is chosen in this example.
8. Determine recommended pharmacist FTE for the patient care area: Staff at 50% x 1 pharmacist FTE
before COVID-19 = 0.5 pharmacist FTE recommended for this post-COVID-19 ICU patient volume
*Assumes unit-based pharmacist coverage for patient care area before COVID-19
†Considers COVID-19 patient complexity with the assumption that these patients require a similar amount of care in
non-Critical Care units. However, if hospitals have COVID-19 units or more severely ill patients, then this table may be
adjusted accordingly based on patient acuity.
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pain management). Clinical pharmacy services
performance demonstrates contributions to
our health system’s overall financial stewardship.
To assist with the reboot of surgical services,
a surgical and procedural operations acceleration checklist was implemented. (Table 1) This
checklist provides detailed directions on medication management processes to restart surgical procedures with the appropriate medication
supply and stock, and important medication
safety components specific to the operating room. To assure safe practices, the ASHP
Guidelines on Perioperative Pharmacy Services
is an encouraged primer to the surgical services
reboot.12

Medication Safety: Provide Tools
to Assess Safe Practices

Medication safety continues to be a priority during COVID-19 and the reboot phase.
Critically ill patients with COVID-19 requiring
ventilator support have complicated medication regimens that may include neuromuscular
blocking agents (e.g., cisatracurium, vecuronium), anticoagulants for venous thromboembolism prophylaxis, medications for the treatment
of COVID-19, bronchodilators (e.g., albuterol,
levalbuterol) and anxiolytic and sedatives.
During periods of COVID-19 surges, non-critical
care units are converted to critical care units to
manage the additional patient volumes. A medication safety playbook is used to emphasize
the importance of sharing medication events
and errors with the team to improve safety
from a systems perspective.
Earlier in the year, a medication safety audit
tool was released to assess patient care unit
and pharmacy services. The most pertinent
sections of the tool, regarding the use of
neuromuscular blocking agents and anticoagulation medication safety, are being used to
identify and address gaps in the system that
may potentially lead to medication errors for
units converted to critical care.13 (Table 3) Routine assessment of operating room medication
safety practices using recommendations from
Wahr et al. may reveal a drift in safety practices
that have occurred during COVID-19.14 When
gaps in safety practices are identified, creating an action plan may be helpful to close gaps
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with the responsible person(s) and corresponding timeline clearly delineated.

Medication Supply: Offer
Medication Shortage,
Conservation and Future Supply
Planning Guidance

As patient volumes increase, hospitals confirm
a sufficient medication supply is in inventory to safely provide patient care. Automated
dispensing cabinet supplies are adjusted for
patient volumes based on projection of services. Savings plans and clinical initiatives are
evaluated to support hospital financial health
(e.g., biosimilar medications, formulary conversions) with guidance that remote, abbreviated
Pharmacy and Therapeutics Committee meeting structures are considered for formulary
modifications. Review of medication supply is
part of the daily huddle discussion along with
educating nursing teams on different medication strengths, sizes and concentrations.
Our supply chain team monitors medication
supply back-orders and provides alternatives to
medications in short supply. Any medications
provided by third party vendors (i.e., 503B pharmacies/outsourcers and/or 503A pharmacies)
continue to be evaluated to identify whether
it would be more cost effective to compound
those medications within the hospital. If medications are less costly to outsource from vendors, medication orders are placed in advance
with quantities estimated based on projected
patient volumes. Personal protective equipment (PPE), such as gloves and gowns used
during medication compounding, are necessities that the supply chain team procures and
manages. Hospital staff is provided the appropriate PPE based on the pharmacist role by the
PPE Czar daily. The PPE Czar role was created
in each hospital to assist with monitoring and
allocating appropriate PPE to employees. Universal masking in patient and visitor areas of
the hospital is a continued practice.

Regulatory Compliance: Ensure
Pharmacy Practices Return
to Regulatory Compliance
Standards

During COVID-19 surges, nurses and providers
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Table 3. Neuromuscular Blocking Agent and Anticoagulant Safety Checklist
NEUROMUSCULAR BLOCKING AGENT (NMB) SAFETY
ID

Observations

Location

Discipline

Participant(s)

Responses

PHARMACY: NMB SAFETY
1

Are NMBs segregated from all other medications in the pharmacy (i.e., placed in separate
lidded containers in the refrigerator or other
secure isolated storage area)?

2

Are auxiliary labels placed on all storage bins
and/or automated dispensing cabinets (ADC)
pockets and drawers that contain NMBs, and
all final medication containers of NMBs (e.g.,
syringes, IV bags) state: "WARNING: PARALYZING AGENT - CAUSES RESPIRATORY ARREST
- PATIENT MUST BE VENTILATED" to clearly
communicate that respiratory paralysis will occur and ventilation is required?

PATIENT CARE UNITS: NMB SAFETY
3

Is NMB storage restricted to only those patient
care units where they are routinely needed (i.e.,
perioperative, labor and delivery, critical care/
intensive care, and emergency settings)?

4

As temporary workforce nurses are deployed
in patient care areas where NMBs are routinely
needed, are nurses educated on high-risk medications and safe guards to reduce harm?

5

In patient care areas where used (e.g., ICU), are
NMBs placed in a sealed box or preferably in a
rapid sequence intubation kit?

6

If vials are stored in ADCs, are they kept in
lock-lidded pockets or lidded bins in the refrigerators (except RSI kits)?

7

Does the ADC clinical alert prompt during NMB
removal? WARNING: PARALYZING AGENT,
CAUSES RESPIRATORY ARREST. IS THE PATIENT VENTILATED or IN THE PROCESS of
BEING VENTILATED?

8

Are nurses able to access NMBs via override
(RSI kit not included)? NOTE: NMBs should NOT
be available on override in the ADC.

9

Was the ADC override report reviewed in the
past 48 hours to evaluate access or process
issues requiring overrides? Document time
elapsed between last review and today's date.

QUALITY PROCESSES AND RISK MANAGEMENT
10 What do you predict the next medication error
will be?
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Table 3. Con’t
ANTICOAGULANT SAFETY
ID

Observations

Location

Discipline

Participant(s)

Responses

INTRAVENOUS INFUSION HEPARIN SAFETY
11

Are smart pumps in use to infuse IV heparin
(e.g., assess patient care unit(s))?

12

Is error-reduction software employed on all
smart pumps for heparin administration (e.g.,
soft and hard maximums)?

13

Is commercially available IV heparin admixture
used?

14

Is heparin provided in a standard concentration
for IV administration (e.g., 100 units/mL)?

15

For IV administration via smart pump, is heparin
set up to infuse in units/kg/hr or mL/hr? [Best
practice set-up does not require nursing to perform calculations.]

ANTIDOTE AND REVERSAL AGENT SAFETY
16

The hospital has a policy that identifies anticoagulant antidotes and reversal agents that
can be administered immediately in emergency
situations?

17

Does the hospital have standard processes in
place to ensure all identified agents are readily
available where needed (e.g., automated dispensing cabinets, pharmacy storage)?

18

Do reversal order sets and protocols exist for
all anticoagulant medications identified in the
policy?

QUALITY PROCESSES AND RISK MANAGEMENT
19

Are ready-to-use concentrations being utilized
(nursing does not have to perform manipulation
before administration)?

are given access or expanded access to medications. The reboot roadmap requirements
include initiating hospital processes to remove
user access when no longer needed and to verify compliance with end dates for exceptions
to regulations issued by the DEA as a result of
COVID-19. Review of pharmacy processes, such
as compounding and security of medications
adjusted, to convert back to previous elements
of performance or regulatory standards is
recommended. Resuming USP <797> and USP
<800> construction placed temporarily on hold
during COVID-19 is an important consideration
to complete and meet regulatory requirements.
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Team Support Opportunities:
Communicating Consistent
Messages

Our health system continues to have monthly enterprise-wide pharmacy leadership and
clinical pharmacy services calls to communicate
relevant, timely information. Pharmacy leadership calls are attended by over 500 directors
of pharmacy and clinical pharmacy managers.
Clinical pharmacy services calls are attended
by clinical pharmacists. A weekly pharmacy
services newsletter is also emailed to pharmacy services leaders, with instruction for the
content to be included in daily staff huddles. All
of these communication mechanisms help to
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convey consistent messaging during the reboot
phase.

Financial Stewardship: Planning
for Resiliency

Our health system’s financial stewardship
resiliency plan encompasses 5 distinct areas:
inventory management and optimization,
labor management, clinical and medication
specific initiatives, technology enhancements
and revenue. Optimizing supply chain and
hospital inventories minimizes excess stock
and maximizes value. Assessing hospital acuity and patient load reflects labor utilization
to ensure efficiency. Assuring that clinical
pharmacy services are continued and patient
regimen reviews are conducted daily is critical
to enhance patient outcomes and minimize
adverse events due to medication therapy. In
the clinical pharmacist workflow, our health
system’s real time surveillance tool was leveraged to prompt pharmacists to address critical
medication management issues and assess
intervention documentation completeness.
Targeting high cost, low evidence medications
decreases direct drug spend. Working with senior leadership to limit physician preference is
vital to the hospital financial stewardship plan.
Evaluating subscription-based technology and
off-contract knowledge solutions software for
cancellation opportunities provides additional
cost savings. Analyzing current billing practices ensures that medications are appropriately
billed for reimbursement. Each area individually
impacts financial performance, and together,
judicious management of all areas results in
overall resiliency.

Discussion

Our health system deployed the reboot roadmap prior to the lifting of stay-at-home restrictions in most communities to prepare our
hospitals and continue to adapt and update
content based on the ever changing healthcare environment. Feedback indicates that the
information is timely and provides direction
to move forward during this challenging time.
When every expenditure is closely evaluated,
this messaging has given pharmacy services an
opportunity to demonstrate commitment to
patient care and to showcase financial performance contributions.

Conclusion

Although COVID-19 disrupted our health system pharmacy services, a roadmap of resiliency strategies with accompanying toolkits,
checklists and guidance supports pharmacy
department planning as comprehensive patient care services are resumed. Reboot tactics
are broadly applicable and adaptable to other
health systems as pharmacy leaders prepare
for increased emergency department visits and
elective surgical services cases, in addition to
articulating the operational and clinical contributions of pharmacy services.
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